Biocon Expects US Success For Biosimilar Trastuzumab Despite Amgen Launch

 
• By Penelope MacRae
Doctor with Mammography - Image
Biocon Confident On Breast Cancer Biosimilar Trastuzumab • Source: Shutterstock

More from India

More from Focus On Asia